JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Home
Signaling Pathways

Signaling Pathways

A8735 XMU-MP-1
2 Citation

Target: MST

Summary: MST1/2 inhibitor, potent and selective

≥41.6 mg/mL
A8217 ICG 001
1 Citation

Summary: Wnt/β-catenin pathway inhibitor

≥27.43 mg/mL
A8240 SB 216763
3 Citation

Target: GSK-3

Summary: GSK-3 inhibitor,ATP-competitive,potent and selective

insoluble in EtOH; insoluble in H2O; ≥56.8 mg/mL
A8327 Verteporfin

Target: YAP

Summary: Photosensitizer used in photodynamic therapy

insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
A8395 CHIR-98014

Target: GSK-3

Summary: GSK-3β inhibitor,selective and ATP-competitive

insoluble in H2O; insoluble in EtOH; ≥8.1 mg/mL
A8685 Wnt-C59
2 Citation

Target: PORCN

Summary: PORCN inhibitor,highly potent and selective

.95 mg/mL

insoluble in H2O; ≥18
A8709 SW033291

Target: 15-PGDH

Summary: 15-PGDH enzyme inhibitor
B5833 GSK503
2 Citation

Summary: EZH2 inhibitor

≥21.65 mg/mL
B2266 LDE225 (NVP-LDE225,Erismodegib)
1 Citation

Target: Smoothened

Summary: Smoothened inhibitor,potent and selective

≥24.3 mg/mL
A8182 3-Deazaneplanocin A (DZNep) hydrochloride
1 Citation

Target: EZH2

Summary: SAHH and EZH2 inhibitor

insoluble in EtOH; ≥14.94 mg/mL